What Is the Total Amount of Symbiotec Pharmalab's IPO?
The Symbiotec Pharmalab Limited IPO is scheduled to open on 24 August 2026 and close on 27 August 2026. The total issue size of the IPO is ₹1,757 crore, making it a significant public offering for investors looking to participate in the pharmaceutical sector.
The IPO price band has been fixed at ₹938 to ₹988 per share, with a minimum lot size of 15 shares. Based on the upper price band, investors will need a minimum investment of ₹14,820 to apply for one lot.
Apply Now: https://medium.com/@piyushchsi2345/what-is-the-total-amount-of-symbiotec-pharmalabs-ipo-7f4426953117
#SymbiotecPharmalabIPO
#SymbiotecPharmalabLimitedIPO
#SymbiotecPharmalabIPOReview
The Symbiotec Pharmalab Limited IPO is scheduled to open on 24 August 2026 and close on 27 August 2026. The total issue size of the IPO is ₹1,757 crore, making it a significant public offering for investors looking to participate in the pharmaceutical sector.
The IPO price band has been fixed at ₹938 to ₹988 per share, with a minimum lot size of 15 shares. Based on the upper price band, investors will need a minimum investment of ₹14,820 to apply for one lot.
Apply Now: https://medium.com/@piyushchsi2345/what-is-the-total-amount-of-symbiotec-pharmalabs-ipo-7f4426953117
#SymbiotecPharmalabIPO
#SymbiotecPharmalabLimitedIPO
#SymbiotecPharmalabIPOReview
What Is the Total Amount of Symbiotec Pharmalab's IPO?
The Symbiotec Pharmalab Limited IPO is scheduled to open on 24 August 2026 and close on 27 August 2026. The total issue size of the IPO is ₹1,757 crore, making it a significant public offering for investors looking to participate in the pharmaceutical sector.
The IPO price band has been fixed at ₹938 to ₹988 per share, with a minimum lot size of 15 shares. Based on the upper price band, investors will need a minimum investment of ₹14,820 to apply for one lot.
Apply Now: https://medium.com/@piyushchsi2345/what-is-the-total-amount-of-symbiotec-pharmalabs-ipo-7f4426953117
#SymbiotecPharmalabIPO
#SymbiotecPharmalabLimitedIPO
#SymbiotecPharmalabIPOReview
0 Σχόλια
0 Μοιράστηκε